Defenx Competitors

Defenx (LON:DFX) and AVEVA Group (LON:AVV) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of current ratings for Defenx and AVEVA Group, as reported by MarketBeat.com.

AVEVA Group has a consensus target price of GBX 4,206.67, suggesting a potential upside of 25.65%.

Profitability

This table compares Defenx and AVEVA Group's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Defenx and AVEVA Group's revenue, earnings per share (EPS) and valuation.

Defenx is trading at a lower price-to-earnings ratio than AVEVA Group, indicating that it is currently the more affordable of the two stocks.

Summary

AVEVA Group beats Defenx on 4 of the 4 factors compared between the two stocks.

The Sage Group (LON:SGE) and Defenx (LON:DFX) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Earnings & Valuation

This table compares The Sage Group and Defenx's revenue, earnings per share and valuation.

Defenx is trading at a lower price-to-earnings ratio than The Sage Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares The Sage Group and Defenx's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings for The Sage Group and Defenx, as provided by MarketBeat.com.

The Sage Group currently has a consensus target price of GBX 615.71, indicating a potential downside of 3.16%.

Summary

The Sage Group beats Defenx on 4 of the 4 factors compared between the two stocks.

Defenx (LON:DFX) and Avast (LON:AVST) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends.

Valuation and Earnings

This table compares Defenx and Avast's revenue, earnings per share and valuation.

Defenx is trading at a lower price-to-earnings ratio than Avast, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Defenx and Avast's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings for Defenx and Avast, as provided by MarketBeat.

Avast has a consensus price target of GBX 542, suggesting a potential upside of 16.99%.

Summary

Avast beats Defenx on 5 of the 5 factors compared between the two stocks.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and Defenx (LON:DFX) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability.

Analyst Recommendations

This is a summary of current ratings and target prices for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and Defenx, as reported by MarketBeat.com.

Valuation & Earnings

This table compares First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and Defenx's top-line revenue, earnings per share (EPS) and valuation.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Defenx, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and Defenx's net margins, return on equity and return on assets.

Summary

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation beats Defenx on 2 of the 3 factors compared between the two stocks.

Defenx (LON:DFX) and Sophos Group plc (SOPH.L) (LON:SOPH) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for Defenx and Sophos Group plc (SOPH.L), as reported by MarketBeat.

Valuation and Earnings

This table compares Defenx and Sophos Group plc (SOPH.L)'s top-line revenue, earnings per share (EPS) and valuation.

Defenx is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Defenx and Sophos Group plc (SOPH.L)'s net margins, return on equity and return on assets.

Summary

Sophos Group plc (SOPH.L) beats Defenx on 3 of the 3 factors compared between the two stocks.

Defenx (LON:DFX) and IntegraFin (LON:IHP) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends and profitability.

Valuation and Earnings

This table compares Defenx and IntegraFin's top-line revenue, earnings per share (EPS) and valuation.

Defenx is trading at a lower price-to-earnings ratio than IntegraFin, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Defenx and IntegraFin's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and price targets for Defenx and IntegraFin, as reported by MarketBeat.

IntegraFin has a consensus target price of GBX 595, suggesting a potential upside of 8.08%.

Summary

IntegraFin beats Defenx on 4 of the 4 factors compared between the two stocks.